David Willner
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 12
- Peptidase Inhibition and Analysis 8
- HER2/EGFR in Cancer Research 4
-
- Click Chemistry and Applications 3
- Co-authors
- Pamela A. Trail (12 shared papers)Shirley J. Lasch (10 shared papers)Raymond A. Firestone (8 shared papers)Sandra J. Hofstead (7 shared papers)Jay O. Knipe (3 shared papers)Ingegerd Hellström (5 shared papers)Gene M. Dubowchik (3 shared papers)K E Hellström (3 shared papers)
- Journals
- Journal of the American Chemical Society (6 papers)Bioconjugate Chemistry (5 papers)Journal of Medicinal Chemistry (3 papers)The Journal of Antibiotics (3 papers)Phytochemistry (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
David Willner
28 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 86
- Radiology, Nuclear Medicine and Imaging 838
- Oncology 828
- Biomaterials 271
- Organic Chemistry 339
- Molecular Biology 801
Countries citing papers authored by David Willner
This map shows the geographic impact of David Willner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Willner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Willner more than expected).
Fields of papers citing papers by David Willner
This network shows the impact of papers produced by David Willner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Willner. The network helps show where David Willner may publish in the future.
Co-authors
The 25 scholars most cited alongside David Willner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 460 | |
| 2 | 1993 | 455 | |
| 3 | 1993 | 194 | |
| 4 | 1991 | 150 | |
| 5 | 2002 | 117 | |
| 6 | 1961 | 88 | |
| 7 | 1999 | 66 | |
| 8 | Antitumor activity of carcinoma-reactive BR96-doxorubicin conjugate against human carcinomas in athymic mice and rats and syngeneic rat carcinomas in immunocompetent rats. | 1997 | 65 |
| 9 | Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models. | 1992 | 53 |
| 10 | Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. | 1997 | 47 |
| 11 | 2002 | 41 | |
| 12 | Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin. | 1999 | 37 |
| 13 | 1996 | 30 | |
| 14 | 1988 | 24 | |
| 15 | 1964 | 24 | |
| 16 | 1964 | 24 | |
| 17 | 1972 | 19 | |
| 18 | 1995 | 15 | |
| 19 | 1958 | 15 | |
| 20 | 1960 | 11 |
About David Willner
David Willner is a scholar working on Oncology, Organic Chemistry, Radiology, Nuclear Medicine and Imaging, Pharmacology and Biotechnology, having authored 29 papers that have together received 2.0k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Research and Treatments (3 papers), Pharmacological Effects of Natural Compounds (3 papers), Advances in Cucurbitaceae Research (3 papers), Cynara cardunculus studies (3 papers) and Click Chemistry and Applications (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (838 citations), Oncology (828 citations), Biomaterials (271 citations), Organic Chemistry (339 citations) and Molecular Biology (801 citations). David Willner has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Pamela A. Trail, Shirley J. Lasch, Raymond A. Firestone, Sandra J. Hofstead, Jay O. Knipe, Ingegerd Hellström, Gene M. Dubowchik, K E Hellström, Arris J. Henderson and Anna Maria Casazza. Their work appears in journals such as Journal of the American Chemical Society, Bioconjugate Chemistry, Journal of Medicinal Chemistry, The Journal of Antibiotics and Phytochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.